Ovulation induction with low-dose follicle-stimulating hormone in women with the polycystic ovary syndrome

References

• MacGregor A H, Johnson J E, Bunde C A. Further clinical experience with clomiphene citrate. Fertil Steril 1968; 19: 616–22
   PubMed Web of Science ®Google Scholar
• Dale P O, Tanbo T, Henriksen T, Magnus ô, Åbyholm T. Gonadotropin therapy of female infertility. Acta Endocrinol (Copenh) 1989; 120: 395–9
   Google Scholar
• Scaramuzzi R J, Davidson W G, Van Look P FA. Increasing ovulation rate in sheep by active immunization against an ovarian steroid androstenedione. Nature 1977; 269: 817–8
   PubMed Web of Science ®Google Scholar
• Stanger J D, Yovich J L. Reduced in vitro fertilization of oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynaecol 1985; 92: 385–90
   PubMedGoogle Scholar
• Anderson R E, Cragun J M, Chang R J, Stanczyk F Z, Lobo R A. A pharmacodynamic comparison of human urinary follicle-stimulating hormone and human menopausal gonadotropin in normal women and polycystic ovary syndrome. Fertil Steril 1989; 52: 216–20
   PubMedGoogle Scholar
• Garcea N, Campo S, Panetta V, Venneri M, Siccardi P, Dargenio R, DeTomasi F. Induction of ovulation with purified urinary follicle-stimulating hormone in patients with polycystic ovarian syndrome. Am J Obstet Gynecol 1985; 151: 635–40
   Google Scholar
• McFaul P B, Traub A I, Thompson W. Treatment of clomiphene citrate-resistant polycystic ovarian syndrome with pure follicle-stimulating hormone or human menopausal gonadotropin. Fertil Steril 1990; 53: 792–7
   Google Scholar
• Fleming R, Haxton M J, Hamilton M PR, McCune G S, Black W R, MacNaughton M C, Coutts J RT. Successful treatment of infertile women with oligomenorrhea using a combination of an LHRH agonist and exogenous gonadotropins. Br J Obstet Gynaecol 1985; 92: 369–73
   PubMedGoogle Scholar
• Lanzone A, Fulghesu M, Spina A, Menini E, Caruso A, Mancuso S. Successful induction of ovulation and conception with the combined gonadotropin-releasing hormone agonist plus highly purified follicle stimulating hormone in patients with polycystic ovarian disease. J Clin Endocrinol Metab 1987; 65: 1253–8
   PubMed Web of Science ®Google Scholar
• Dale P O, Tanbo T, Åbyholm T. In-vitro fertilization in infertile women with the polycystic ovarian syndrome. Hum Reprod 1991; 6: 238–41
   PubMed Web of Science ®Google Scholar
• Lunde O. Polycystic ovarian syndrome; a retrospective study of the therapeutic effect of ovarian wedge resection after unsuccessful treatment with clomiphene citrate. Ann Chir Gynecol 1982; 71: 330–3
   PubMedGoogle Scholar
• Gjônnaess H. The course and outcome of pregnancy after ovarian electrocautery in women with polycystic ovarian syndrome: the influence of body weight. Br J Obstet Gynaecol 1985; 96: 714–9
   Google Scholar
• Buttram V C, Vaquero C. Post ovarian wedge resection adhesive disease. Fertil Steril 1975; 26: 874–6
   PubMedGoogle Scholar
• Kamrawa M M, Seibel M M, Berger M J, Thompson I, Tay-Mor M L. Reversal of persistent anovulation in polycystic ovarian disease by administration of chronic low-dose follicle-stimulating hormone. Fertil Steril 1982; 37: 520–3
   PubMedGoogle Scholar
• Poison D W, Mason H D, Saldahna M BY, Franks S. Ovulation of a single dominant follicle during treatment with low-dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome. Clin Endocrinol 1987; 26: 205–12
   Google Scholar
• Adams J, Poison D W, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 1986; 293: 355–9
   PubMed Web of Science ®Google Scholar
• Dale P O, Tanbo T, Haug E, Åbyholm T. GnRH-agonist therapy in women with the polycystic ovarian syndrome: effects on ovarian volume and on gonadotropin and sex steroid levels. Gynecol Endocrinol 1989; 3: 309–15
   Web of Science ®Google Scholar
• Seibel M M, McArdle C, Smith D, Taymor M L. Ovulation induction in polycystic ovary syndrome with urinary follicle-stimulating hormone or human menopausal gonadotropin. Fertil Steril 1985; 43: 703–8
   PubMed Web of Science ®Google Scholar
• Hamilton-Fairley D, Kiddy D, Watson H, Sagle M, Franks S. Low-dose gonadotropin therapy of ovulation in 100 women with polycystic ovary syndrome. Hum Reprod 1991; 6: 1095–9
   PubMed Web of Science ®Google Scholar
• Homburg R, Armar N A, Eshel J, Adams J, Jacobs H S. Influence of serum luteinizing hormone concentrations on ovulation, conception and early pregnancy loss in polycystic ovary syndrome. Br Med J 1988; 297: 1024–6
   PubMed Web of Science ®Google Scholar
• Buvat J B, Buvat-Herbaut M, Marcolin G, Dehaene J L, Verbecq P, Renouard O. Purified follicle-stimulating hormone in polycystic ovary syndrome: slow administration is safer and more effective. Fertil Steril 1989; 52: 553–9
   Google Scholar
• Sagle M A, Hamilton-Fairley D, Kiddy D S, Franks S. A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome. Fertil Steril 1991; 55: 56–60
   Google Scholar